As of January 2021, all articles accepted and published in Quantitative Biology are fully Open Access: immediately freely available to read, download and share.
Submissions will be subject to an APC if accepted and published in the journal: $1,100 USD / £910 GBP / €1,050 EUR
This journal offers discounts for select article types:
Technical Note, Protocol, Data Article, Short Communication, Method: $550 USD / £460 GBP / €530 EUR
Commentary, Perspective: $280 USD / £230 GBP / €260 EUR
Profile, Editorial: 100% discount
Automatic APC waivers or discounts will be given to Corresponding Authors from institutions in countries and locations on the Waivers and Discounts List. There is no action for authors.
If the Corresponding Author's institution, funder, or society has a Wiley Open Access Account (WOAA), all or part of the APC might be covered. Eligibility is based on the article's submission date and the organization having an active account/partnership arrangement when the article is ready to be published.
The prices quoted do not include any value-added tax (VAT), goods and services tax (GST), or other sales taxes. Tax may be charged in addition to the price shown where required by law. The amount of tax charged will be calculated at the point of sale and identified separately.
If you have a VAT, GST, or other sales tax identification number, you should provide this when requested.
If you or the party responsible for payment are tax exempt, instructions will be provided during the payment process regarding where and when to send the tax exemption certificate or other relevant documentation.
Quantitative Biology is an Open Access journal: authors of accepted articles pay an article publication charge, and their articles are published under a Creative Commons license.
All authors must use the CC BY Creative Commons License.
Certain funders mandate a particular type of CC license be used. For more information about the licenses offered by this journal, please visit Wiley Author Services.
Quantitative Biology accepts advertisements that are relevant to the journal’s subject community, promote high quality products and services, and are provided by reputable organizations who display a true commitment to science and medicine. This journal can earn revenue from advertising sales income.
Wiley’s advertising policy safeguards editorial autonomy and mitigates potential conflicts of interest.
Wiley advertising sales activities conform to applicable ICMJE advertising recommendations, and all advertising campaigns served against editorial content are subject to the ICMJE recommendations. Our policies align with industry standards, guidelines, and best practices. Advertisers, agencies, and partners promoting their products on Wiley platforms follow regulations set forth by the appropriate regional governing bodies.
Wiley targets advertising based on publication, taxonomy, geography, behavior, and opted-in audience demographics. User specific targeting only applies to individuals who have willingly and explicitly agreed to share their personal data as per our privacy policy. For more information about this journal’s advertising policy, please contact corpsolutions@wiley.com.